Duffy, B.; McNulty, H.; Ward, M.; Psara, E.; O’Sullivan, E.; Horigan, G.; Pentieva, K.
Riboflavin Status in Pregnancy and Its Relationship with Blood Pressure, Heart Rate and Risk of Hypertension: Findings from the OptiPREG Observational Study. Proceedings 2023, 91, 27.
https://doi.org/10.3390/proceedings2023091027
AMA Style
Duffy B, McNulty H, Ward M, Psara E, O’Sullivan E, Horigan G, Pentieva K.
Riboflavin Status in Pregnancy and Its Relationship with Blood Pressure, Heart Rate and Risk of Hypertension: Findings from the OptiPREG Observational Study. Proceedings. 2023; 91(1):27.
https://doi.org/10.3390/proceedings2023091027
Chicago/Turabian Style
Duffy, Bethany, Helene McNulty, Mary Ward, Elina Psara, Emma O’Sullivan, Geraldine Horigan, and Kristina Pentieva.
2023. "Riboflavin Status in Pregnancy and Its Relationship with Blood Pressure, Heart Rate and Risk of Hypertension: Findings from the OptiPREG Observational Study" Proceedings 91, no. 1: 27.
https://doi.org/10.3390/proceedings2023091027
APA Style
Duffy, B., McNulty, H., Ward, M., Psara, E., O’Sullivan, E., Horigan, G., & Pentieva, K.
(2023). Riboflavin Status in Pregnancy and Its Relationship with Blood Pressure, Heart Rate and Risk of Hypertension: Findings from the OptiPREG Observational Study. Proceedings, 91(1), 27.
https://doi.org/10.3390/proceedings2023091027
